Subscribe to RSS
DOI: 10.1055/s-0042-1751508
Synthesis and Properties of 2′-Deoxyadenosine Mimics Bearing a Thieno[3,2-d]pyrimidine Ring
This work was supported by a Grant-in-Aid for Early-Career Scientists (Grant Number 20K15963 for Y.F.) from the Japan Society for Promotion Sciences (JSPS).
Abstract
A C-nucleoside with a stable C–C glycosidic bond can be used as a building block for chemically modified oligonucleotides (ONs). In this study, two adenosine-like C-nucleosides (dSA and dSO2A) bearing thieno[3,2-d]pyrimidine rings were designed and synthesized. These analogues were synthesized via the Heck reaction, and their properties as monomer nucleosides were investigated. Both the dSA and dSO2A monomers were not recognized by adenosine deaminase (ADA). In addition, they exhibited fluorescence emissions in the UV and visible regions of dSA and dSO2A, respectively. Subsequently, dSA was converted into a phosphoramidite compound and incorporated into the ONs. The synthesized dSA-modified ONs formed a stable duplex with DNA and RNA complements comparable to natural adenosine. Furthermore, the modified ONs exhibited fluorescence emission derived from dSA.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0042-1751508.
- Supporting Information
Publication History
Received: 24 July 2023
Accepted after revision: 12 September 2023
Article published online:
18 October 2023
© 2023. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References and Notes
- 1 Zhang M, Kong L, Gong R, Iorio M, Donadio S, Deng Z, Sosio M, Chen W. Microb. Cell Fact. 2022; 21: 1
- 3a Nishimura H, Mayama M, Komatsu Y, Kato H, Shimaoka N, Tanaka Y. J Antibiot. 1964; 17: 148
- 3b Nakagawa Y, Kano H, Tsukuda Y, Koyama H. Tetrahedron Lett. 1967; 8: 4105
- 4a Koyama G, Maeda K, Umezawa H, Iitaka Y. Tetrahedron Lett. 1966; 7: 597
- 4b Robins RK, Townsend LB, Cassidy F, Gerster JF, Lewis AF, Miller RL. J. Heterocycl. Chem. 1966; 3: 110
- 4c Wang SA, Ko Y, Zeng J, Geng Y, Ren D, Ogasawara Y, Irani S, Zhang Y, Liu HW. J. Am. Chem. Soc. 2019; 141: 6127
- 5a Morais P, Adachi H, Yu YT. Front. Cell Dev. Biol. 2021; 9: 1
- 5b Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Mol. Ther. 2008; 16: 1833
- 6a Bzowska A, Kulikowska E, Shugar D. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1992; 1120: 239
- 6b Long MC, Parker WB. Biochem. Pharmacol. 2006; 71: 1671
- 6c Wierzchowski J, Antosiewicz JM, Shugar D. Mol. Biosyst. 2014; 10: 2756
- 7a Ward DC, Reich E. Proc. Natl. Acad. Sci. U.S.A. 1968; 61: 1494
- 7b Ward DC, Cerami A, Reich E, Acs G, Altwerger L. J. Biol. Chem. 1969; 244: 3243
- 8a De Clercq E. J. Med. Chem. 2016; 59: 2301
- 8b Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, Hall MD. ACS Cent. Sci. 2020; 6: 672
- 8c Cho A, Zhang L, Xu J, Babusis D, Butler T, Lee R, Saunders OL, Wang T, Parrish J, Perry J, Feng JY, Ray AS, Kim CU. Bioorg. Med. Chem. Lett. 2012; 22: 4127
- 9a Shin D, Sinkeldam RW, Tor Y. J. Am. Chem. Soc. 2011; 133: 14912
- 9b Rovira AR, Fin A, Tor Y. J. Am. Chem. Soc. 2015; 137: 14602
- 9c Rovira AR, Fin A, Tor Y. Chem. Sci. 2017; 8: 2983
- 10a Park S, Otomo H, Zheng L, Sugiyama H. Chem. Commun. 2014; 50: 1573
- 10b Lefoix M, Mathis G, Kleinmann T, Truffert J.-C, Asseline U. J. Org. Chem. 2014; 79: 3221
- 11 Shao X, Abdelkhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT. J. Med. Chem. 2019; 62: 9772
- 12 Temburnikar KW, Zimmermann SC, Kim NT, Ross CR, Gelbmann C, Salomon CE, Wilson GM, Balzarini J, Seley-Radtke KL. Bioorg. Med. Chem. 2014; 22: 2113
- 13 Kemnitzer W, Sirisoma N, May C, Tseng B, Drewe J, Cai SX. Bioorg. Med. Chem. Lett. 2009; 19: 3536
- 14 Tor Y, Del Valle S, Jaramillo D, Srivatsan SG, Rios A, Weizman H. Tetrahedron 2007; 63: 3608
- 15a Wellington KW, Benner SA. Nucleosides, Nucleotides Nucleic Acids 2006; 25: 1309
- 15b Stambaský J, Hocek M, Kočovský P. Chem. Rev. 2009; 109: 6729
- 16 Hegelein A, Müller D, Größl S, Göbel M, Hengesbach M, Schwalbe H. Chem. Eur. J. 2020; 26: 1800
- 17 Synthesis of dSA To a solution of compound 5 (38 mg, 70 μmol) in CH2Cl2 (1 mL), TFA (0.2 mL) was added at room temperature under an argon atmosphere. The reaction mixture was stirred for 17 h followed by addition of MeOH. The resulting mixture was concentrated in vacuo. Subsequently, CHCl3 was added to the residue, and the resulting precipitate was collected by filtration. The collected solid was dried in vacuo to obtain compound dSA (15 mg, 81%) as a white solid. IR (ATR): 3329, 3200, 2924, 1643, 1579, 1513 cm–1. 1H NMR (500 MHz, CD3OD): δ = 8.33 (1 H, s), 7.98 (1 H, s), 5.49 (1 H, dd, J = 11.0, 5.5 Hz), 4.46 (1 H, d, J = 5.5 Hz), 4.06–4.05 (1 H, m), 3.81 (1 H, dd, J = 12.0, 3.0 Hz), 3.71 (1 H, dd, J = 12.0, 3.0 Hz), 2.42 (1 H, ddd, J = 13.0, 11.0, 5.5 Hz), 2.22 (1 H, dd, J = 13.0, 5.5 Hz). 13C NMR (125 MHz, CD3OD): δ = 160.4, 157.7, 154.8, 138.1, 131.4, 117.4, 89.7, 77.9, 75.2, 64.5, 58.3, 49.8, 43.0, 18.4. HRMS (ESI-TOF): m/z [M – H]– calcd for C11H12N3O3S: 266.0599; found: 266.0599.
- 18 Synthesis of dSO2A To a solution of compound 9 (289 mg, 0.5 mmol) in CH2Cl2 (5 mL), TFA (0.25 mL) was added at room temperature under an argon atmosphere. The reaction mixture was stirred for 2 days and then quenched with NaHCO3 and MeOH. The resulting mixture was filtered, and then the filtrate was concentrated in vacuo. Subsequently, a solution of CHCl3/MeOH (1:1) was added to the residue, and the resulting precipitate was collected by filtration. The collected solid was dried in vacuo to obtain compound dSO2A (92 mg, 62%) as a gray solid. IR (ATR): 3508, 3376, 3331, 3135, 3084, 1670, 1591, 1537, 1499 cm–1. 1H NMR (500 MHz, DMSO-d 6): δ = 8.58 (1 H, s), 7.95 (2 H, br s), 7.46 (1 H, d, J = 2.0 Hz), 5.15 (1 H, d, J = 5.0 Hz), 5.12 (1 H, ddd, J = 10.0, 6.0, 2.0, Hz), 4.77 (1 H, t, J = 6.0 Hz), 4.19–4.18 (1 H, m), 3.80 (1 H, dt, J = 5.0, 2.0 Hz), 3.45–3.36 (2 H, m), 2.31 (1 H, ddd, J = 13.0, 6.0, 2.0 Hz), 1.79 (1 H, ddd, J = 13.0, 10.0, 5.0 Hz). 13C NMR (125 MHz, DMSO-d 6): δ = 162.2, 158.1, 154.4, 148.1, 129.2, 109.0, 87.6, 72.9, 71.8, 62.0, 40.5. HRMS (ESI-TOF): m/z [M + Na]+ calcd for C11H13N3O5NaS: 322.0468; found: 322.0474.
- 19 Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Med. Res. Rev. 2001; 21: 105
- 20 An authentic sample of dSI was successfully obtained in 78% yield by the chemical conversion of dSA (see the Supporting Information). In contrast, for the preparation of an authentic sample of dSO2I, the chemical conversion of dSO2A into the corresponding dSO2I could not be achieved because of the low reactivity of the 4-amino group of dSO2A.
- 21 Sinkeldam RW, McCoy LS, Shin D, Tor Y. Angew. Chem. Int. Ed. 2013; 52: 14026
- 22 Ludford PT, Yang S, Bucardo MS, Tor Y. Chem. Eur. J. 2022; 28: e202104472
- 23 Chen RF. Anal. Lett. 1967; 1: 35
- 24 Heinlein T, Knemeyer JP, Piestert O, Sauer M. J. Phys. Chem. B 2003; 107: 7957